BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration

Reuters

12/10

BUZZ-Australia's <a href="https://laohu8.com/S/RHYN.AU">Rhythm Biosciences</a> gains on cancer test collaboration

** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week

** Stock hits highest since December 3

** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England

** ColoSTAT test is a blood-based test used to detect colorectal cancer

** YTD, RHY down ~6%

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2590037422"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2590037422\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2590037422?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-10 11:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590037422","market":"us","top_or_hot":-1,"title":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> gains on cancer test collaboration</title></head><body><p>** <a href=\"https://laohu8.com/S/RHYBF\">Rhythm Biosciences</a> <span>RHY.AX</span> rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week</p><p>** Stock hits highest since December 3</p><p>** Medical diagnostics co <span>enters</span> collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England</p><p>** ColoSTAT test is a blood-based test used to detect colorectal cancer</p><p>** YTD, RHY down ~6%</p><p> (Reporting by Aamir Sheik Khalid in Bengaluru)</p><p> ((Aamir.SheikKhalid@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-10 11:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> gains on cancer test collaboration</title></head><body><p>** <a href=\"https://laohu8.com/S/RHYBF\">Rhythm Biosciences</a> <span>RHY.AX</span> rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week</p><p>** Stock hits highest since December 3</p><p>** Medical diagnostics co <span>enters</span> collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England</p><p>** ColoSTAT test is a blood-based test used to detect colorectal cancer</p><p>** YTD, RHY down ~6%</p><p> (Reporting by Aamir Sheik Khalid in Bengaluru)</p><p> ((Aamir.SheikKhalid@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7124","symbol_name":"保健护理服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL6N3XG05W:1","article_id":"2590037422","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590037422","pubTimestamp":1765336642,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week** Stock hits highest since December 3** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England** ColoSTAT test is a blood-based test used to detect colorectal cancer** YTD, RHY down ~6%  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7124":"保健护理服务","RHY.AU":"RHYTHM BIOSCIENCES LTD"},"translate_title":"BUZZ-澳大利亚Rhythm Biosciences在癌症测试合作中取得进展","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RHY.AU":0.9},"content_text":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week** Stock hits highest since December 3** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England** ColoSTAT test is a blood-based test used to detect colorectal cancer** YTD, RHY down ~6% (Reporting by Aamir Sheik Khalid in Bengaluru) ((Aamir.SheikKhalid@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}